NEW YORK (GenomeWeb News) – Investigators at the Polytechnic Institute of New York University and NYU plan to use a $1.2 million grant from the National Institutes of Health to study how histones may be involved in cancer and diabetes, NYU-Poly said today.

The research team plans to use computational chemistry and protein engineering approaches to study these scaffolding proteins, which are modified by enzymes called histone acetyltransferases, or HATs. Those changes can then affect gene expression.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.